Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Defining the role of tissue resident immune cells in promoting or inhibiting ischemia reperfusion injury (IRI) and poorer clinical outcomes in kidney transplantation.
FY 2020-21
Summary
Ischemia reperfusion injury (IRI) refers to damage caused when blood supply returns to an organ after oxygen deprivation, which can lead to severe malfunction of the organ. Notably, patients who receive kidney transplants from deceased donors have higher rates of IRI, rejection and damage compared to patients that receive transplants from living donors. Recent studies have identified discrete immune populations, such as innate lymphoid cells (ILCs), that promote tissue repair and aid in reducing damage caused by IRI. While certain subsets of ILCs contribute to inflammatory immune responses, other subsets control inflammation and promote tissue repair. However, the role of ILCs within IRI and kidney transplantation is not known. This research will examine the contribution of ILCs and other tissue-resident immune populations in protecting kidneys from transplant rejection and IRI. We suspect that kidneys from deceased donors contain fewer protective ILCs than kidneys from living donors, which may contribute to higher risk of IRI and rejection. Using advanced computational platforms, we will perform in-depth analyses of ILCs and other immune cells in deceased donors and living donors pre- and post- transplantation. This will involve analyzing cellular interactions and functional characteristics to identify protective and harmful immune cells in transplanted kidneys. The ultimate goal of this research is to define harmful immune cells that can be targeted to lower the risk of IRI in deceased donor transplants or identify protective immune cells to harness in cell-based immune therapies for transplantation. This will lead to improved patient recovery, more successful transplants, and reduced kidney disease morbidity.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449340
Name
Mak Martin L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Defining the role of tissue resident immune cells in promoting or inhibiting ischemia reperfusion injury (IRI) and poorer clinical outcomes in kidney transplantation.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Deceased Donor; Differences Between Deceased And Living; Graft Function; Graft Rejection; Immune Cell Differences; Ischemia Reperfusion Injury; Kidney; Rnaseq; Transplantation; Transplantation Injury
Abstract
Ischemia reperfusion injury (IRI) refers to damage caused when blood supply returns to an organ after oxygen deprivation, which can lead to severe malfunction of the organ. Notably, patients who receive kidney transplants from deceased donors have higher rates of IRI, rejection and damage compared to patients that receive transplants from living donors. Recent studies have identified discrete immune populations, such as innate lymphoid cells (ILCs), that promote tissue repair and aid in reducing damage caused by IRI. While certain subsets of ILCs contribute to inflammatory immune responses, other subsets control inflammation and promote tissue repair. However, the role of ILCs within IRI and kidney transplantation is not known. This research will examine the contribution of ILCs and other tissue-resident immune populations in protecting kidneys from transplant rejection and IRI. We suspect that kidneys from deceased donors contain fewer protective ILCs than kidneys from living donors, which may contribute to higher risk of IRI and rejection. Using advanced computational platforms, we will perform in-depth analyses of ILCs and other immune cells in deceased donors and living donors pre- and post- transplantation. This will involve analyzing cellular interactions and functional characteristics to identify protective and harmful immune cells in transplanted kidneys. The ultimate goal of this research is to define harmful immune cells that can be targeted to lower the risk of IRI in deceased donor transplants or identify protective immune cells to harness in cell-based immune therapies for transplantation. This will lead to improved patient recovery, more successful transplants, and reduced kidney disease morbidity.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mak, Martin L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~